EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSMMMG00000017826
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSMMMG00000001803
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSMMMG00000013798
Gene Symbol: PTGIR
1 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSMMMG00000018619
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMMMG00000013357
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSMMMG00000003002
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSMMMG00000012134
Gene Symbol: PSMA2
3 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMMMG00000005482
Gene Symbol: PSMA3
3 Cross references
225 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMMMG00000001281
Gene Symbol: PSMA4
3 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMMMG00000020437
Gene Symbol: PSMA5
3 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMMMG00000006439
Gene Symbol: PSMA6
3 Cross references
272 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSMMMG00000004668
Gene Symbol: PSMA7
2 Cross references
119 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).